BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+6.18%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$17.6B
AUM Growth
+$17.6B
(+1.3%)
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
87.48%
Holding
123
New
5
Increased
24
Reduced
7
Closed
6
Top Buys
| 1 |
Replimune Group
REPL
|
$34.6M |
| 2 |
Ascendis Pharma
ASND
|
$28.9M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$21.7M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$19.9M |
| 5 |
Nurix Therapeutics
NRIX
|
$18.1M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$63.5M |
| 2 |
Legend Biotech
LEGN
|
$63.4M |
| 3 |
Axsome Therapeutics
AXSM
|
$25.3M |
| 4 |
Merus
MRUS
|
$23.6M |
| 5 |
Sarepta Therapeutics
SRPT
|
$9.64M |
Sector Composition
| 1 | Healthcare | 99.17% |
